down arrow

Medicamen Biotec

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE646B01010
  • NSEID: MEDICAMEQ
  • BSEID: 531146
INR
499.60
6.6 (1.34%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 16.83 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
12.71
15.26
12.22
12.22
12.22
11.70
Share Warrants & Outstandings
Total Reserve
194.27
178.16
134.25
120.67
109.00
74.93
Shareholder's Funds
206.98
193.41
146.47
132.89
121.22
86.63
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
1.26
0.87
5.07
6.40
2.36
0.02
Secured Loans
1.26
0.87
5.07
6.40
2.36
0.02
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-2.51
-1.88
-0.50
0.28
0.16
0.41
Other Long Term Liabilities
0.000000000
0
0.000000000
0.000000000
0
0.000000000
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.76
1.66
1.46
1.16
1.06
0.98
Total Non-Current Liabilities
0.50
0.65
6.04
7.84
3.58
1.42
Current Liabilities
Trade Payables
38.95
47.59
43.30
32.21
37.38
30.57
Other Current Liabilities
15.12
10.98
9.29
9.50
5.91
0.78
Short Term Borrowings
29.56
23.31
19.27
10.93
7.62
11.61
Short Term Provisions
0.92
0.69
0.82
0.63
5.57
5.58
Total Current Liabilities
84.56
82.57
72.69
53.27
56.48
48.54
Total Liabilities
292.04
276.64
225.20
194.01
181.28
136.59
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
136.70
130.43
124.26
115.66
57.74
46.58
Less: Accumulated Depreciation
44.85
37.77
31.78
26.02
24.05
22.20
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
91.85
92.66
92.48
89.64
33.69
24.38
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
40.50
14.76
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
1.22
1.11
0.87
0.78
0.63
0.58
Other Non Current Assets
39.37
19.51
8.82
7.56
2.33
0.70
Total Non-Current Assets
132.44
113.28
102.16
97.97
77.15
40.42
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
59.38
45.06
27.01
5.20
16.96
15.26
Sundry Debtors
55.26
65.26
63.22
52.55
49.96
43.37
Cash and Bank
14.79
20.78
3.82
3.89
3.09
8.52
Other Current Assets
22.17
21.98
19.55
22.52
21.08
14.35
Short Term Loans and Advances
8.00
10.29
9.43
11.87
13.04
14.67
Total Current Assets
159.59
163.36
123.04
96.03
104.13
96.17
Net Current Assets (Including Current Investments)
75.04
80.79
50.35
42.76
47.65
47.62
Total Current Assets Excluding Current Investments
159.59
163.36
123.04
96.03
104.13
96.17
Miscellaneous Expenses not written off
6.70
7.06
7.74
6.66
2.04
0.42
Total Assets
292.04
276.64
225.20
194.01
181.28
136.59
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
30.82
24.18
24.35
17.33
9.97
11.63
Book Value per share (adjusted)
162.79
150.82
119.89
108.78
99.22
74.05
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is 27.46% vs -0.70% in Mar 2023

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is -0.87% vs 0.19% in Mar 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is -2.31% vs 32.77% in Mar 2023

Compare Balance Sheet Results of Medicamen Biotec
Markets Mojo
Figures in Rs cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.71
40.06
-27.35
-68.27%
Share Warrants & Outstandings
Total Reserve
194.27
9,299.78
-9,105.51
-97.91%
Shareholder's Funds
206.98
9,363.09
-9,156.11
-97.79%
Minority Interest
0.00
212.70
-212.70
-100.00%
Long-Term Borrowings
1.26
24.87
-23.61
-94.93%
Secured Loans
1.26
24.87
-23.61
-94.93%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-2.51
8.67
-11.18
-128.95%
Other Long Term Liabilities
0.00
30.68
-30.68
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.76
123.12
-121.36
-98.57%
Total Non-Current Liabilities
0.50
187.34
-186.84
-99.73%
Current Liabilities
Trade Payables
38.95
1,102.99
-1,064.04
-96.47%
Other Current Liabilities
15.12
456.26
-441.14
-96.69%
Short Term Borrowings
29.56
171.17
-141.61
-82.73%
Short Term Provisions
0.92
389.31
-388.39
-99.76%
Total Current Liabilities
84.56
2,119.73
-2,035.17
-96.01%
Total Liabilities
292.04
11,882.86
-11,590.82
-97.54%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
136.70
5,775.71
-5,639.01
-97.63%
Less: Accumulated Depreciation
44.85
1,354.82
-1,309.97
-96.69%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
91.85
4,420.89
-4,329.04
-97.92%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
207.09
-207.09
-100.00%
Intangible assets under development
0.00
74.70
-74.70
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
315.12
-315.12
-100.00%
Long Term Loans & Advances
1.22
163.97
-162.75
-99.26%
Other Non Current Assets
39.37
13.79
25.58
185.50%
Total Non-Current Assets
132.44
5,314.63
-5,182.19
-97.51%
Current Assets Loans & Advances
Current Investments
0.00
2,258.11
-2,258.11
-100.00%
Inventories
59.38
1,553.46
-1,494.08
-96.18%
Sundry Debtors
55.26
848.28
-793.02
-93.49%
Cash and Bank
14.79
1,197.97
-1,183.18
-98.77%
Other Current Assets
22.17
106.80
-84.63
-79.24%
Short Term Loans and Advances
8.00
610.77
-602.77
-98.69%
Total Current Assets
159.59
6,568.23
-6,408.64
-97.57%
Net Current Assets (Including Current Investments)
75.04
4,448.50
-4,373.46
-98.31%
Total Current Assets Excluding Current Investments
159.59
4,310.11
-4,150.52
-96.30%
Miscellaneous Expenses not written off
6.70
0.00
6.70
0.00%
Total Assets
292.04
11,882.86
-11,590.82
-97.54%
Contingent Liabilities
0.00
116.23
-116.23
-100.00%
Total Debt
30.82
196.04
-165.22
-84.28%
Book Value per share (adjusted)
162.79
233.73
-70.94
-30.35%
Annual - Borrowings
Borrowings 30.82 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 27.46% vs -0.70% in Mar 2023

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 91.85 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -0.87% vs 0.19% in Mar 2023

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 159.59 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -2.31% vs 32.77% in Mar 2023